These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10347638)

  • 1. [Practice guidelines to physicians and their economic aspects; merits and drawbacks].
    Stehouwer CD
    Ned Tijdschr Geneeskd; 1999 Apr; 143(15):776-8. PubMed ID: 10347638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic analysis for clinical practice--the case of 31 national consensus guidelines in the Netherlands.
    Niessen LW; Grijseels E; Koopmanschap M; Rutten F;
    J Eval Clin Pract; 2007 Feb; 13(1):68-78. PubMed ID: 17286726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Medical decisions, cost considerations and clinical practice guidelines; comments from the legal point of view].
    Gevers JK; Biesaart MC
    Ned Tijdschr Geneeskd; 1999 Dec; 143(52):2629-32. PubMed ID: 10633810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines--are they useful?
    Ben-Menachem E; French JA
    Epilepsia; 2006; 47 Suppl 1():62-4. PubMed ID: 17044829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ['Cholesterol' guideline (first revision) of the Dutch College of Family Physicians; response from the family practice].
    van den Bosch WJ
    Ned Tijdschr Geneeskd; 2000 Feb; 144(9):404-7. PubMed ID: 10719541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. U.S. statin guidelines: expensive but not necessarily effective.
    Barry HC; Hoffman JR
    Am Fam Physician; 2007 May; 75(10):1453-4, 1456. PubMed ID: 17555139
    [No Abstract]   [Full Text] [Related]  

  • 9. Barriers to following National Cholesterol Educational Program guidelines. An appraisal of poor physician compliance.
    Fix KN; Oberman A
    Arch Intern Med; 1992 Dec; 152(12):2385-7. PubMed ID: 1456846
    [No Abstract]   [Full Text] [Related]  

  • 10. How should treatment costs impact on physician's decisions?
    Neymark N
    Acta Otorhinolaryngol Belg; 1999; 53(3):289-92. PubMed ID: 10635410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cholesterol-lowering therapy; a recommendation from the Health Council].
    Comans ML
    Ned Tijdschr Geneeskd; 2001 Feb; 145(5):244. PubMed ID: 11219155
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-benefit issues in the practice of internal medicine.
    Friedman RB; Katt JA
    Arch Intern Med; 1991 Jun; 151(6):1165-8. PubMed ID: 1904213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are nonspecific practice guidelines potentially harmful? A randomized comparison of the effect of nonspecific versus specific guidelines on physician decision making.
    Shekelle PG; Kravitz RL; Beart J; Marger M; Wang M; Lee M
    Health Serv Res; 2000 Mar; 34(7):1429-48. PubMed ID: 10737446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
    Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
    Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cholesterol-lowering therapy; a recommendation from the Health Council].
    Simoons ML
    Ned Tijdschr Geneeskd; 2000 Dec; 144(51):2442-4. PubMed ID: 11151651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of HMG coenzyme reductase inhibitors; whom to treat?
    van Hout BA; Simoons ML
    Eur Heart J; 2001 May; 22(9):751-61. PubMed ID: 11350107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gap between guidelines and practice: attainment of treatment targets in patients with primary hypercholesterolemia starting statin therapy. Results of the 4E-Registry (Efficacy Calculation and Measurement of Cardiovascular and Cerebrovascular Events Including Physicians' Experience and Evaluation).
    Assmann G; Benecke H; Neiss A; Cullen P; Schulte H; Bestehorn K
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):776-83. PubMed ID: 17001218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Issues of consensus and debate for economic evaluation in rheumatology.
    Coyle D; Welch V; Shea B; Gabriel S; Drummond M; Tugwell P
    J Rheumatol; 2001 Mar; 28(3):642-7. PubMed ID: 11296975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physician knowledge levels and barriers to coronary risk prevention in women: survey results from the Women and Heart Disease Physician Education Initiative.
    Barnhart J; Lewis V; Houghton JL; Charney P
    Womens Health Issues; 2007; 17(2):93-100. PubMed ID: 17403466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Which cholesterol-lowering drugs should be used in the primary prevention of cardiovascular disease?].
    Fretheim A; Bjørndal A; Oxman AD; Dyrdal A; Golding M; Ose L; Reikvam A; Teisberg P
    Tidsskr Nor Laegeforen; 2002 Sep; 122(23):2287-8. PubMed ID: 12448270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.